Vicarious Surgical RBOT Income Statement (2020-2025)

OTC RBOT
$0.05 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT
Reported Financials

Vicarious Surgical Quarterly Income Statement

Periods 23 quarters
Latest Dec 2025

Vicarious Surgical income statement data for the quarter ended Dec 2025. This income statement covers 23 quarters of results from Jun 2020 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating items
Research & DevelopmentR&D
3.61M4.01M5.19M9.26M9.85M10.05M12.12M11.88M13.36M12.71M13.04M8.47M9.97M10.92M10.80M8.46M9.41M9.05M7.99M
Selling, General & AdministrativeSG&A
1.40M2.28M2.53M7.00M6.93M7.76M8.13M6.89M7.00M7.08M6.91M5.87M5.00M5.59M5.75M5.54M5.29M4.12M3.16M
Restructuring CostsRestructuring
0.13M1.51M
Other Operating ExpensesOther Opex
0.10M0.33M0.84M1.57M-0.11M1.31M1.91M1.84M1.96M1.67M1.40M1.20M1.14M1.20M1.21M0.98M1.04M0.35M0.35M
Operating ExpensesOpex
5.23M6.61M8.56M17.82M18.18M19.13M22.16M20.61M22.32M21.46M21.35M15.54M16.11M17.71M17.75M14.98M15.75M13.52M11.50M
Operating IncomeOp. Inc
-5.23M-6.61M-8.56M-17.82M-18.18M-19.13M-22.16M-20.61M-22.32M-21.46M-21.35M-15.54M-16.11M-17.71M-17.75M-14.98M-15.75M-13.52M-11.50M
EBIT
-5.23M-6.61M-8.56M-17.82M-18.18M-19.13M-22.16M-20.61M-22.32M-21.46M-21.35M-15.54M-16.11M-17.71M-17.75M-14.98M-15.75M-13.52M-11.50M
Non-operating items
Non Operating Interest Expenses
0.00M0.03M0.03M0.03M0.03M0.03M0.03M0.11M0.00M0.00M0.00M0.02M
Non Operating Investment IncomeNon-Op. Investment Inc.
0.07M0.01M0.07M-0.20M0.04M0.10M-0.05M-0.01M0.17M-0.07M-0.03M-0.02M
Interest & Investment IncomeInt & Inv Inc
0.00M0.00M-0.00M0.02M0.01M0.10M0.49M0.83M1.47M1.04M0.95M0.97M0.97M0.92M0.80M0.59M0.45M0.26M0.16M
Other Non Operating IncomeOther Non Op Inc.
-19.57M-1.59M0.09M-0.04M
Non Operating IncomeNon Op. Inc.
0.35M
Net income details
EBT
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.33M-15.70M-13.11M-17.00M-15.21M-17.09M-13.93M-15.39M-13.21M-11.06M
Profit After TaxPAT
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.53M-15.70M-13.02M-17.05M-15.21M-17.09M-13.93M-15.43M-13.23M-11.06M
Income from Non-Controlling InterestsInc. Minority
-21.03M0.89M-2.51M-0.35M-0.30M
Income from Continuing OperationsIncome (Continuing)
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.33M-15.70M-13.11M-17.00M-15.21M-17.09M-13.93M-15.39M-13.21M-11.06M
Consolidated Net IncomeConsol Net Inc.
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.33M-15.70M-13.11M-17.00M-15.21M-17.09M-13.93M-15.39M-13.21M-11.06M
Income towards Parent CompanyParent Net Inc
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.33M-15.70M-13.11M-17.00M-15.21M-17.09M-13.93M-15.39M-13.21M-11.06M
Net Income towards Common StockholdersNet Income
-5.23M-6.64M-45.12M21.79M42.53M-1.45M-24.74M-11.18M-26.92M-15.33M-15.70M-13.11M-17.00M-15.21M-17.09M-13.93M-15.39M-13.21M-11.06M
Additional items
EPS (Basic)
-3.64-5.77-14.686.7610.00-0.36-6.09-2.75-6.40-3.62-3.04-2.69-2.90-2.59-2.90-2.37-2.60-2.23-1.86
EPS (Diluted)
-1.79-2.27-14.686.7610.61-0.36-6.09-2.63-6.40-3.62-3.04-2.69-2.90-2.59-2.90-2.37-2.60-2.23-1.86
Shares Outstanding
1.44M1.15M3.07M3.22M4.25M4.04M4.07M4.06M4.20M4.23M5.17M4.87M5.86M5.87M5.90M5.89M5.92M5.94M5.95M5.95M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
2.92M2.93M3.07M3.22M4.01M4.04M4.07M4.25M4.20M4.23M5.17M4.87M5.86M5.87M5.90M5.89M5.92M5.94M5.95M5.95M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
1.44M1.15M3.95M7.98M8.74M8.11M8.81M9.05M8.44M8.48M11.66M11.70M10.77M11.78M11.82M11.84M11.86M11.90M11.92M
EBITDA
-5.23M-6.61M-8.56M-17.82M-18.18M-19.13M-22.16M-20.61M-22.32M-21.46M-21.35M-15.54M-16.11M-17.71M-17.75M-14.98M-15.75M-13.52M-11.50M
Interest ExpensesInt Expense
0.00M0.03M0.03M0.03M0.03M0.03M0.03M0.11M0.00M0.00M0.00M0.02M